KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Interest & Investment Income: 2011-2020

Historic Interest & Investment Income for Supernus Pharmaceuticals (SUPN) over the last 9 years, with Sep 2020 value amounting to $3.3 million.

  • Supernus Pharmaceuticals' Interest & Investment Income fell 41.32% to $3.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $19.8 million, marking a year-over-year decrease of 1.76%. This contributed to the annual value of $13.8 million for FY2018, which is 383.34% up from last year.
  • As of Q3 2020, Supernus Pharmaceuticals' Interest & Investment Income stood at $3.3 million, which was down 41.49% from $5.6 million recorded in Q2 2020.
  • Supernus Pharmaceuticals' Interest & Investment Income's 5-year high stood at $5.6 million during Q2 2020, with a 5-year trough of $327,000 in Q1 2016.
  • For the 3-year period, Supernus Pharmaceuticals' Interest & Investment Income averaged around $4.3 million, with its median value being $4.5 million (2018).
  • Per our database at Business Quant, Supernus Pharmaceuticals' Interest & Investment Income spiked by 458.54% in 2018 and then plummeted by 41.32% in 2020.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Interest & Investment Income stood at $396,000 in 2016, then soared by 117.68% to $862,000 in 2017, then soared by 423.43% to $4.5 million in 2018, then climbed by 24.61% to $5.6 million in 2019, then crashed by 41.32% to $3.3 million in 2020.
  • Its Interest & Investment Income stands at $3.3 million for Q3 2020, versus $5.6 million for Q2 2020 and $5.6 million for Q3 2019.